Js Capital Management LLC Fate Therapeutics Inc Transaction History

Js Capital Management LLC

  • $240 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$67.25 - $92.52 $269,000 - $370,080
-4,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$72.16 - $117.4 $288,640 - $469,600
4,000 New
4,000 $330,000
Q3 2020

Nov 16, 2020
SELL
$30.41 - $40.5 $276,731 - $368,550
-9,100 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$20.21 - $35.23 $183,911 - $320,593
9,100 New
9,100 $312,000

Others Institutions Holding FATE

# of Institutions
178
Shares Held
124M
Call Options Held
222K
Put Options Held
48.6K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $312M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email